Knights Of Columbus Asset Advisors LLC Revance Therapeutics, Inc. Transaction History

Knights Of Columbus Asset Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$23.23 - $34.3 $1.16 Million - $1.72 Million	-50,002 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$12.6 - $26.55 $198,790 - $418,879	-15,777 Reduced 23.98%	50,002 $1.22 Million
Q1 2020 May 15, 2020	SELL	$12.46 - $27.81 $513,152 - $1.15 Million	-41,184 Reduced 38.5%	65,779 $974,000
Q4 2019 Feb 14, 2020	BUY	$11.66 - $20.15 $1.25 Million - $2.16 Million	106,963 New	106,963 $1.74 Million

234

82.8M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Knights Of Columbus Asset Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Knights Of Columbus Asset Advisors LLC with notifications on news.